Dose counters for inhalers, inhalers and methods of assembly thereof

Patent metadata

Field	Value
Publication number	US-10022510-B2
Application number	US-201615271738-A
Country	US
Kind code	B2
Filing date	Sep 21, 2016
Priority date	May 18, 2010
Publication date	Jul 17, 2018
Grant date	Jul 17, 2018

Abstract

A tape system for a dose counter for an inhaler, the tape system having a main elongate tape structure, dosing indicia located on the main elongate tape structure, tape positioning indicia located on the main elongate tape structure, a tape size marker located on the main elongate tape structure indicating a number of dosing indicia on the tape, and priming indicia located on the main elongate tape structure, the priming indicia being located between the dosing indicia and one end of the tape.

First claim

What is claimed is:

1. An inhaler comprising a dose counter and dose counter viewing window, the inhaler being configured to be readied by priming before first use and the dose counter comprising:
a tape system having a main elongate tape structure, dosing indicia located on the main elongate tape structure, tape positioning indicia located on the main elongate tape structure, a tape size marker located on the main elongate tape structure indicating a number of dosing indicia on the main elongate tape structure, and priming indicia located on the main elongate tape structure, the priming indicia being located between the dosing indicia and a first end of the main elongate tape structure and visible in the dose counter viewing window before priming before first use, and
wherein the first end of the main elongate tape structure is fixed to a tape reel shaft and a second end of the main elongate tape structure is attached to a stock bobbin, and wherein the main elongate tape structure is around both the stock bobbin and tape reel shaft when the priming indicia is visible in the dose counter viewing window before priming before first use.

2. The inhaler of claim 1 , wherein the dosing indicia comprise numbers printed on the main elongate tape structure.

3. The inhaler of claim 1 , wherein the priming indicia is a priming dot located on the main elongate tape structure that is to be aligned with the viewing window on the inhaler that is visible to a user of the inhaler.

4. The inhaler of claim 1 , wherein the tape positioning indicia comprise a series of lines that are each formed across the main elongate tape structure.

5. The inhaler of claim 1 , wherein the tape size marker is positioned between said one the first end of the main elongate tape structure and the tape positioning indicia.

6. The inhaler of claim 1 , wherein the tape positioning indicia are positioned between the first end of the main elongate tape structure and the dosing indicia.

7. The inhaler of claim 1 , wherein the first end of the main elongate tape structure is fixed to the tape reel shaft.

8. The inhaler of claim 1 , wherein the priming indicia is positioned between the dosing indicia and the tape positioning indicia.

9. The inhaler of claim 1 , wherein the tape size marker is a pixelated bar code.

10. An inhaler comprising a dose counter and dose counter viewing window, the inhaler being configured to be readied by priming before first use and the dose counter comprising:
a tape system having a main elongate tape structure, dosing indicia located on the main elongate tape structure, tape positioning indicia located on the main elongate tape structure, and a tape size marker located on the main elongate tape structure indicating a number of dosing indicia on the main elongate tape structure, wherein the tape size marker is positioned between a first end of the main elongate tape structure and the tape positioning indicia,
wherein the first end of the main elongate tape structure is fixed to a tape reel shaft and a second end of the main elongate tape structure is attached to a stock bobbin, and wherein the tape is around both the stock bobbin and tape reel shaft and a portion of the main elongate tape structure between the tape positioning indicia and the dosing indicia is visible in the dose counter viewing window before priming before first use.

11. The inhaler of claim 10 , wherein the dosing indicia comprise numbers printed on the main elongate tape structure.

12. The inhaler of claim 10 , wherein the tape positioning indicia comprise a series of lines that are each formed across the main elongate tape structure.

13. The inhaler of claim 10 , wherein the tape size marker is positioned between the first end of the main elongate tape structure and the dosing indicia.

14. The inhaler of claim 10 , wherein the tape size marker is a pixelated bar code.

15. The inhaler of claim 10 , wherein said the first of the main elongate tape structure is fixed to the tape reel shaft.

16. The inhaler of claim 10 further comprising priming indicia located on the main elongate tape structure, the priming indicia being located between the dosing indicia and the first end of the main elongate tape structure.

17. The inhaler of claim 16 , wherein the tape positioning indicia are positioned between the first end of the tape and the dosing indicia.

18. The inhaler of claim 16 , wherein the priming indicia are positioned between the dosing indicia and the tape positioning indicia.

19. The inhaler of claim 16 , wherein the priming indicia is a priming dot located on the main elongate tape structure that is to be aligned with the viewing window.

20. An inhaler comprising a dose counter and dose counter viewing window, the inhaler being configured to be readied by priming before first use and the dose counter comprising:
a tape system having a main elongate tape structure, dosing indicia located on the main elongate tape structure, tape positioning indicia located on the main elongate tape structure so as to be visible in the dose counter viewing window before priming before first use, and priming indicia located on the main elongate tape structure, the priming indicia being located between the tape positioning indicia and the dosing indicia,
wherein a first end of the main elongate tape structure is attached to a stock bobbin and a second end of the main elongate tape structure is fixed to a tape reel shaft, and wherein the main elongate tape structure is around both the stock bobbin and tape reel shaft when the priming indicia is visible in the dose counter viewing window before priming before first use.

21. The inhaler of claim 20 , wherein the dosing indicia comprise numbers printed on the main elongate tape structure.

22. The inhaler of claim 20 , wherein the priming indicia is a priming dot located on the main elongate tape structure that is to be aligned with the viewing window on the inhaler that is visible to a user of the inhaler.

23. The inhaler of claim 20 , wherein the tape positioning indicia comprise a series of lines that are each formed across the main elongate tape structure.

Assignees

• Ivax Pharmaceuticals Ireland
• Norton Waterford Ltd
• Teva Pharma Ireland
• Ivax Pharmaeuticals Ireland

Inventors

• Walsh Declan
• Fenlon Derek
• Kaar Simon
• Hazenberg Jan Geert
• Buck Daniel
• Clancy Paul
• Uschold Robert Charles
• Karg Jeffrey A

Classifications

• A61M2207/00

  Methods of manufacture, assembly or production · CPC title

• A61M11/00 Primary

  Sprayers or atomisers specially adapted for therapeutic purposes (in general B05B; {aerosol containers B65D83/14}) · CPC title

• A61M15/0071

  having a display or indicator · CPC title

• A61M15/009

  using medicine packages with incorporated spraying means, e.g. aerosol cans (pocket atomiser of the injector type A61M11/08) · CPC title

• A61M15/0025

  with caps · CPC title